483 BioMarin Pharmaceutical Mar 2009

483 BioMarin Pharmaceutical Mar 2009

Lance De Souza FDA, William Millar FDA, Rochelle Young FDA$119.00 - Available Now

FDA investigators audited the BioMarin Pharmaceutical - Novato, CA, United States facility and issued 2 inspectional observations (via FDA 483) on 20 Mar 2009.

Product details

  • Category: Human Drugs
  • Number of Observations: 2
  • Inspection end: 20 Mar 2009
  • Location: Novato, United States
  • FEI: 3004079983
Add To Cart